Brad Schreck
Totowa, NJ (USA)
Role(s):
C-Level Executive (CEO, CFO, etc.)
VectraCor
Find More Startups
Startup
Location:
Totowa
Industry:
Bio-Technology
Year Founded:
2009
Number Employees:
10-50 people
Business Stage:
Growth (not profitable)
Entity Type:
"C" Corporation
Description:
VectraCor is a high technology medical device company with a disruptive technology for the number 1 killer in the world, Cardiovascular Disease. Our patented technology can detect a heart attack, noninvasively in real time with our CEB, Cardiac Electrical Biomarker, and derive a 15 - 22 lead ECG with only 5 electrodes on the patient.
VectraCor has FDA approval, CE mark, Australian and Taiwan registrations with ~$2M in sales and ready to launch worldwide. Several studies have been published or active from prestigious hospitals such as; The Cleveland Clinic, Johns Hopkins, Henry Ford Health System, Baylor Scott & White Health, Summit Medical Group and Atlantic Health Systems, University of Basel.
We expect a 5-10X return.
Please visit website for more info (URL removed) . Please dot hesitate to call my cell is (Phone # removed).